VRTHF (Indigenous Bloom Hemp) Debt-to-EBITDA : -5.98 (As of Feb. 2023)

What is Indigenous Bloom Hemp Debt-to-EBITDA?

Indigenous Bloom Hemp VRTHF -99.93% Debt-to-EBITDA is -5.98 as of Feb. 2023.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Indigenous Bloom Hemp's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2023 was $0.53 Mil. Indigenous Bloom Hemp's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2023 was $0.00 Mil. Indigenous Bloom Hemp's annualized EBITDA for the quarter that ended in Feb. 2023 was $-0.09 Mil. Indigenous Bloom Hemp's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2023 was -5.98.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Indigenous Bloom Hemp's Debt-to-EBITDA or its related term are showing as below:

VRTHF's Debt-to-EBITDA is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.65
* Ranked among companies with meaningful Debt-to-EBITDA only.

Indigenous Bloom Hemp (OTCPK:VRTHF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Indigenous Bloom Hemp Debt-to-EBITDA Related Terms

Indigenous Bloom Hemp Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Indigenous Bloom Hemp's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indigenous Bloom Hemp Debt-to-EBITDA Chart

Indigenous Bloom Hemp Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

May22

Debt-to-EBITDA

Get a 7-Day Free Trial

0.00

-0.12

-0.33

Indigenous Bloom Hemp Quarterly Data
	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Nov21	Feb22	May22	Aug22	Feb23
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.03	-4.31	-0.12	-2.05	-5.98

VRTHF vs ZTS: Debt-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Indigenous Bloom Hemp's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indigenous Bloom Hemp Debt-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indigenous Bloom Hemp's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Indigenous Bloom Hemp's Debt-to-EBITDA falls into.

Save Embed

Indigenous Bloom Hemp Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Indigenous Bloom Hemp's Debt-to-EBITDA for the fiscal year that ended in May. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.54	+	0.01)	/	-1.689
	=	-0.33

Indigenous Bloom Hemp's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.526	+	0)	/	-0.088
	=	-5.98

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Feb. 2023) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →

What does a Debt-to-EBITDA of -5.98 mean?

Indigenous Bloom Hemp (VRTHF) has a Debt-to-EBITDA of -5.98 as of Feb. 2023. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Indigenous Bloom Hemp.

Is Indigenous Bloom Hemp's Debt-to-EBITDA too high?

Indigenous Bloom Hemp's current Debt-to-EBITDA is -5.98.

How does Indigenous Bloom Hemp's Debt-to-EBITDA compare to ZTS?

Indigenous Bloom Hemp's Debt-to-EBITDA of -5.98 can be compared against companies in the Drug Manufacturers industry. The industry median Debt-to-EBITDA is 1.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Debt-to-EBITDA for a Drug Manufacturers company?

The median Debt-to-EBITDA among Drug Manufacturers companies is 1.65, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Debt-to-EBITDA mean?

A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Indigenous Bloom Hemp. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indigenous Bloom Hemp's current Debt-to-EBITDA is -5.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Indigenous Bloom Hemp stock overvalued right now?

Indigenous Bloom Hemp (VRTHF) has a current Debt-to-EBITDA of -5.98. The current Debt-to-EBITDA is -5.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Debt-to-EBITDA calculated?

Debt-to-EBITDA is calculated from a company's financial statements. For Indigenous Bloom Hemp (VRTHF), the current Debt-to-EBITDA is -5.98 as of Feb. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indigenous Bloom Hemp Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XCNQ:MJ XCNQ:PLNT.X XCNQ:OVAT XCNQ:GSL XCNQ:BIO TSXV:NU XCNQ:SE XCNQ:XCX XCNQ:MJRX XCNQ:MGW ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Address c/o 3200 650 West Georgia Street, Vancouver, BC, CAN, V6B 4P7

Website https://www.indigenousbloomcorporate.com

Indigenous Bloom Hemp Corp is in business to produce and sell hemp extracts.